Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Delanoy

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Health Informatics Journal|May 16, 2022
Identifying homogeneous healthcare use profiles and treatment sequences by combining sequence pattern mining with care trajectory clustering in kidney cancer patients on oral anticancer drugs: A case studyCyril Baudrier, Yohann Tran, Nicolas Delanoy, et al.
BMC Psychiatry|February 23, 2019
The impact of the Paris terrorist attacks on the mental health of resident physiciansJules Gregory, Jean de Lepinau, Ariane de Buyer, et al.
Journal of Gynecology Obstetrics and Human Reproduction|June 1, 2022
Synchronous low grade endometrioid endometrial and ovarian cancer: Focus on therapeutic de-escalation proposed by the latest 2020 ESMO/ESTRO/ESP guidelinesThomas Dabreteau, Meriem Koual, Nicolas Delanoy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 27, 2015
Bleomycin-Induced Pneumonitis in the Treatment of Ovarian Sex Cord-Stromal Tumors: A Systematic Review and Meta-analysisNicolas Delanoy, Nicolas Pécuchet, Elizabeth Fabre, et al.
European Journal of Cancer Care|December 19, 2020
Pharmaceutical consultation to detect drug interactions in patients treated with oral chemotherapies: A descriptive cross-sectional studyCélia Lachuer, Germain Perrin, Aymeric Chastel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2024
Dynamic changes in <i>TP53</i> mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomasMaria Kfoury, Clément Bonnet, Nicolas Delanoy, et al.
Clinical Genitourinary Cancer|March 19, 2023
Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor TherapyAntonin Broyelle, Nicolas Delanoy, André-Michel Bimbai, et al.
Future Oncology (London, England)|January 19, 2021
Cabazitaxel schedules in metastatic castration-resistant prostate cancer: a reviewCedric Pobel, Edouard Auclin, Adrien Procureur, et al.
Journal of Clinical Medicine|January 22, 2021
Clinical Impact of Lymphadenectomy after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Review of Available DataStephanie Seidler, Meriem Koual, Guillaume Achen, et al.
Cancers|April 3, 2021
Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA StudyNicolas Delanoy, Debbie Robbrecht, Mario Eisenberger, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Health Informatics Journal|May 16, 2022
Identifying homogeneous healthcare use profiles and treatment sequences by combining sequence pattern mining with care trajectory clustering in kidney cancer patients on oral anticancer drugs: A case studyCyril Baudrier, Yohann Tran, Nicolas Delanoy, et al.
BMC Psychiatry|February 23, 2019
The impact of the Paris terrorist attacks on the mental health of resident physiciansJules Gregory, Jean de Lepinau, Ariane de Buyer, et al.
Journal of Gynecology Obstetrics and Human Reproduction|June 1, 2022
Synchronous low grade endometrioid endometrial and ovarian cancer: Focus on therapeutic de-escalation proposed by the latest 2020 ESMO/ESTRO/ESP guidelinesThomas Dabreteau, Meriem Koual, Nicolas Delanoy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 27, 2015
Bleomycin-Induced Pneumonitis in the Treatment of Ovarian Sex Cord-Stromal Tumors: A Systematic Review and Meta-analysisNicolas Delanoy, Nicolas Pécuchet, Elizabeth Fabre, et al.
European Journal of Cancer Care|December 19, 2020
Pharmaceutical consultation to detect drug interactions in patients treated with oral chemotherapies: A descriptive cross-sectional studyCélia Lachuer, Germain Perrin, Aymeric Chastel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2024
Dynamic changes in <i>TP53</i> mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomasMaria Kfoury, Clément Bonnet, Nicolas Delanoy, et al.
Clinical Genitourinary Cancer|March 19, 2023
Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor TherapyAntonin Broyelle, Nicolas Delanoy, André-Michel Bimbai, et al.
Future Oncology (London, England)|January 19, 2021
Cabazitaxel schedules in metastatic castration-resistant prostate cancer: a reviewCedric Pobel, Edouard Auclin, Adrien Procureur, et al.
Journal of Clinical Medicine|January 22, 2021
Clinical Impact of Lymphadenectomy after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Review of Available DataStephanie Seidler, Meriem Koual, Guillaume Achen, et al.
Cancers|April 3, 2021
Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA StudyNicolas Delanoy, Debbie Robbrecht, Mario Eisenberger, et al.
Pageof 4